Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 17, 2020 07:00 ET | Source: Unity Biotechnology, Inc.

UNITY Biotechnology Announces 12-week data from UBX0101 Phase 2 Clinical Study in Patients with Painful Osteoarthritis of the Knee

UBX0101 failed to meet 12-week primary endpointGuidance for UNITY’s Bcl-xL inhibitor UBX1325 in retinal disease remains unchangedUNITY to focus senescence programs on ophthalmologic and neurologic...
August 04, 2020 16:05 ET | Source: Unity Biotechnology, Inc.

UNITY Biotechnology Announces $80M Debt Financing From Hercules Capital

SAN FRANCISCO, Aug. 04, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing...
July 31, 2020 07:57 ET | Source: Unity Biotechnology, Inc.

UNITY Biotechnology, Inc. Reports Second Quarter 2020 Financial Results and Clinical Program Updates

SOUTH SAN FRANCISCO, Calif., July 31, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing,...
July 29, 2020 16:05 ET | Source: Unity Biotechnology, Inc.

UPDATE – UNITY Biotechnology, Inc. to Announce Second Quarter 2020 Financial Results

SAN FRANCISCO, July 29, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing...
July 24, 2020 08:00 ET | Source: Unity Biotechnology, Inc.

UNITY Biotechnology, Inc. to Announce Second Quarter 2020 Financial Results

SAN FRANCISCO, July 24, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing...
July 06, 2020 17:00 ET | Source: Unity Biotechnology, Inc.

UNITY Biotechnology Announces CFO Transition

SAN FRANCISCO, July 06, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
July 01, 2020 16:05 ET | Source: Unity Biotechnology, Inc.

UNITY Biotechnology, Inc. Provides Updates on Lead Development Programs

– Topline 12-week results for Phase 2 study of UBX0101 in osteoarthritis expected in 3Q 2020 – – First-in-human study for UBX1325 in age-related eye disease expected to commence in 2H 2020 – SOUTH...
June 11, 2020 14:31 ET | Source: Unity Biotechnology, Inc.

UNITY Biotechnology to Participate in Fireside Chat at the Goldman Sachs 41st Annual Global Healthcare Conference

SAN FRANCISCO, June 11, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing...
May 28, 2020 16:05 ET | Source: Unity Biotechnology, Inc.

UNITY Biotechnology to Participate in the Goldman Sachs 41st Annual Global Healthcare Conference

SAN FRANCISCO, May 28, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing...
May 07, 2020 16:05 ET | Source: Unity Biotechnology, Inc.

UNITY Biotechnology, Inc. Reports First Quarter 2020 Financial Results and Business Updates

SOUTH SAN FRANCISCO, Calif., May 07, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting...